| Effect of allopurinol in chronic kidney disease progression and cardiovascular risk M Goicoechea, SG de Vinuesa, U Verdalles, C Ruiz-Caro, J Ampuero, ... Clinical Journal of the American Society of Nephrology 5 (8), 1388-1393, 2010 | 1017 | 2010 |
| COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ... Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020 | 434 | 2020 |
| COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain M Goicoechea, LAS Cámara, N Macías, AM de Morales, ÁG Rojas, ... Kidney international 98 (1), 27-34, 2020 | 413 | 2020 |
| Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD M Gracia, A Betriu, M Martinez-Alonso, D Arroyo, M Abajo, E Fernandez, ... Clinical Journal of the American Society of Nephrology 11 (2), 287-296, 2016 | 76 | 2016 |
| Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: baseline data from the NEFRONA … D Arroyo, A Betriu, M Martinez-Alonso, T Vidal, JM Valdivielso, ... Bmc Nephrology 15, 1-10, 2014 | 67 | 2014 |
| Autosomal dominant tubulointerstitial kidney disease: clinical presentation of patients with ADTKD-UMOD and ADTKD-MUC1 N Ayasreh, G Bullich, R Miquel, M Furlano, P Ruiz, L Lorente, O Valero, ... American Journal of Kidney Diseases 72 (3), 411-418, 2018 | 64 | 2018 |
| Present and future in the treatment of diabetic kidney disease B Quiroga, D Arroyo, G de Arriba Journal of diabetes research 2015 (1), 801348, 2015 | 64 | 2015 |
| Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus J Caro, E Gutiérrez-Solís, J Rojas-Rivera, I Agraz, N Ramos, C Rabasco, ... Nephrology Dialysis Transplantation 30 (3), 467-474, 2015 | 58 | 2015 |
| Aspirin for primary prevention of cardiovascular disease and renal disease progression in chronic kidney disease patients: a multicenter randomized clinical trial (AASER Study) M Goicoechea, SG de Vinuesa, B Quiroga, E Verde, C Bernis, E Morales, ... Cardiovascular drugs and therapy 32, 255-263, 2018 | 55 | 2018 |
| Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality L Rojas, P Muñoz, M Kestler, D Arroyo, M Guembe, ... Journal of Hospital Infection 85 (3), 196-205, 2013 | 51 | 2013 |
| New perspectives on CKD-induced dyslipidemia M Bermúdez-López, D Arroyo, À Betriu, L Masana, E Fernández, ... Expert opinion on therapeutic targets 21 (10), 967-976, 2017 | 50 | 2017 |
| An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients M Bermudez-Lopez, C Forne, N Amigo, M Bozic, D Arroyo, T Bretones, ... Expert opinion on therapeutic targets 23 (7), 619-630, 2019 | 44 | 2019 |
| Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study D Arroyo, A Betriu, J Valls, JL Gorriz, V Pallares, M Abajo, M Gracia, ... Nephrology Dialysis Transplantation 32 (3), 513-520, 2017 | 44 | 2017 |
| Albumin leakage in online hemodiafiltration, more convective transport, more losses? A Vega, B Quiroga, S Abad, I Aragoncillo, D Arroyo, N Panizo, ... Therapeutic Apheresis and Dialysis 19 (3), 267-271, 2015 | 44 | 2015 |
| Metformin‐associated acute kidney injury and lactic acidosis D Arroyo, R Melero, N Panizo, M Goicoechea, P Rodríguez-Benítez, ... International journal of nephrology 2011 (1), 749653, 2011 | 44 | 2011 |
| Intraindividual interleukin-6 variations on the cardiovascular prognosis of patients with chronic renal disease M Goicoechea, B Quiroga, S García de Vinuesa, Ú Verdalles, J Reque, ... Renal failure 34 (8), 1002-1009, 2012 | 42 | 2012 |
| Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project À Betriu, C Farràs, M Abajo, M Martinez-Alonso, D Arroyo, F Barbé, M Buti, ... Nefrología (English Edition) 36 (4), 389-396, 2016 | 38* | 2016 |
| Intraperitoneal fluid overestimates hydration status assessment by bioimpedance spectroscopy D Arroyo, N Panizo, S Abad, A Vega, A Rincón, AP De José, ... Peritoneal Dialysis International 35 (1), 85-89, 2015 | 32 | 2015 |
| Chronic kidney disease progression in patients with autosomal dominant polycystic kidney disease N Panizo, M Goicoechea, S García de Vinuesa, D Arroyo, C Yuste, ... Nefrología (English Edition) 32 (2), 197-205, 2012 | 32* | 2012 |
| Utility of bioimpedance spectroscopy (BIS) in the management of refractory hypertension in patients with chronic kidney disease (CKD) U Verdalles, SG de Vinuesa, M Goicoechea, B Quiroga, J Reque, ... Nephrology Dialysis Transplantation 27 (suppl_4), iv31-iv35, 2012 | 30 | 2012 |
Jose M ValdivielsoInstitut de Recerca Biomedica de Lleida在 medicina.udl.es 的电子邮件经过验证
